During the past decade, Encompass Clinical Research conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 39 clinical trials were completed, i.e. on average, 102.6% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 22 clinical trials were completed. i.e. 146.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Encompass Clinical Research" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "Pfizer" with 9 trials sponsored, "AstraZeneca" with 4 trials sponsored, "Shire" with 4 trials sponsored and "Allergan" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Encompass Clinical Research" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Institut de Recherches Internationales Servier" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Encompass Clinical Research" are "Type 2 Diabetes Mellitus" (8 trials), "Type 2 Diabetes" (6 trials), "Diabetes Mellitus, Type 2" (5 trials), "Migraine" (4 trials) and "Attention Deficit Hyperactivity Disorder" (3 trials). Many other conditions were trialed in "Encompass Clinical Research" in a lesser frequency.

Most popular intervention types in "Encompass Clinical Research" are "Drug" (59 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Tirzepatide" (5 trials), "Metformin" (4 trials), "Insulin Degludec" (3 trials) and "CNTX-4975-05" (2 trials). Other intervention names were less common.

The vast majority of trials in "Encompass Clinical Research" are 64 trials for "All" genders.

Currently, there are NaN active trials in "Encompass Clinical Research". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Encompass Clinical Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Encompass Clinical Research, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".